Cell Separation for Liquid Biopsy

About SynderBio

SynderBio is a private, pre-revenue biotech firm founded in 2019, focusing on a proprietary cell separation platform. Its core technology addresses critical sample preparation bottlenecks in genomic sequencing, particularly for complex samples like tumors and immune cells. The company's initial market focus is on oncology and immunology research and diagnostics, with the potential to expand into various life science tools and services. As an early-stage platform company, its success hinges on commercial adoption, partnership development, and demonstrating clear advantages over existing sample preparation methods.

Therapeutic Areas

Other Cancer Diagnostics Drugs